HRP20100651T1 - 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINI S AKTIVNOSCU INHIBITORA PDE-5 - Google Patents

5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINI S AKTIVNOSCU INHIBITORA PDE-5 Download PDF

Info

Publication number: HRP20100651T1
Authority: HR; Croatia
Prior art keywords: ring; compound according; nitrogen; alkyl; optionally substituted
Prior art date: 2003-11-24

Application number

HR20100651T

Other languages

English (en)

Croatian (hr)

Inventor

Simon Bell Andrew

Graham Brown David

Neil Dack Kevin

Nathan A. Fox David

Roger Marsh Ian

Ian Morrell Andrew

John Palmer Michael

Ann Winslow Carol

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-24

Filing date

2004-11-12

Publication date

2011-01-31

2004-11-12 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2011-01-31 Publication of HRP20100651T1 publication Critical patent/HRP20100651T1/hr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HR20100651T 2003-11-24 2004-11-12 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINI S AKTIVNOSCU INHIBITORA PDE-5 HRP20100651T1 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0327319.0A GB0327319D0 (en)	2003-11-24	2003-11-24	Novel pharmaceuticals
PCT/IB2004/003747 WO2005049616A1 (en)	2003-11-24	2004-11-12	5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY

Publications (1)

Publication Number	Publication Date
HRP20100651T1 true HRP20100651T1 (hr)	2011-01-31

Family

ID=29764364

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20100651T HRP20100651T1 (hr)	2003-11-24	2004-11-12	5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINI S AKTIVNOSCU INHIBITORA PDE-5

Country Status (43)

Country	Link
EP (1)	EP1689751B1 (xx)
JP (1)	JP4056015B2 (xx)
KR (2)	KR100848216B1 (xx)
CN (4)	CN101647802A (xx)
AP (1)	AP2227A (xx)
AR (1)	AR046711A1 (xx)
AT (1)	ATE485297T1 (xx)
AU (1)	AU2004290643B2 (xx)
BR (1)	BRPI0416869A (xx)
CA (1)	CA2546987C (xx)
CR (1)	CR8416A (xx)
CY (1)	CY1110933T1 (xx)
DE (1)	DE602004029705D1 (xx)
DK (1)	DK1689751T3 (xx)
EA (1)	EA011772B1 (xx)
EC (1)	ECSP066580A (xx)
ES (1)	ES2351622T3 (xx)
GB (1)	GB0327319D0 (xx)
GE (1)	GEP20084528B (xx)
HR (1)	HRP20100651T1 (xx)
IL (1)	IL175433A (xx)
IS (1)	IS8406A (xx)
MA (1)	MA28172A1 (xx)
ME (1)	ME01216B (xx)
MX (1)	MXPA06005914A (xx)
MY (1)	MY140872A (xx)
NL (1)	NL1027568C2 (xx)
NO (1)	NO336526B1 (xx)
NZ (1)	NZ548097A (xx)
OA (1)	OA13289A (xx)
PA (1)	PA8617701A1 (xx)
PE (1)	PE20051061A1 (xx)
PL (1)	PL1689751T3 (xx)
PT (1)	PT1689751E (xx)
RS (1)	RS51556B (xx)
SG (1)	SG133614A1 (xx)
SI (1)	SI1689751T1 (xx)
TN (1)	TNSN06154A1 (xx)
TW (1)	TWI265031B (xx)
UA (1)	UA81994C2 (xx)
UY (1)	UY28625A1 (xx)
WO (1)	WO2005049616A1 (xx)
ZA (1)	ZA200602899B (xx)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7951805B2 (en)	2004-09-20	2011-05-31	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
US7829712B2 (en)	2004-09-20	2010-11-09	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
JP2008513515A (ja)	2004-09-20	2008-05-01	ゼノン・ファーマシューティカルズ・インコーポレイテッド	複素環誘導体および治療薬としてのそれらの使用
WO2006034279A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
AU2005286647A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
US7919496B2 (en)	2004-09-20	2011-04-05	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
AR051093A1 (es)	2004-09-20	2006-12-20	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de estearoil-coa desaturasa
EP1809632A2 (en) *	2004-10-28	2007-07-25	Pharmacia & Upjohn Company LLC	Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors
PT1881985E (pt) *	2005-05-12	2011-02-01	Pfizer	Formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n- -etil-n-metilamino)-7-(4-metilpiridin-2-il-amino)-1h- -pirazolo[4,3-d]pirimidino-3-carbonil]metanossulfonamida
WO2007130075A1 (en)	2005-06-03	2007-11-15	Xenon Pharmaceuticals Inc.	Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
NL1029244C2 (nl) *	2005-06-10	2006-12-12	Ronald Silfried Marlin	Middel ter vergroting van het mannelijk geslachtsorgaan.
DE102005050377A1 (de) *	2005-10-21	2007-04-26	Bayer Healthcare Ag	Heterocyclische Verbindungen und ihre Verwendung
NL2000291C2 (nl) *	2005-11-10	2009-02-17	Pfizer Prod Inc	1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
WO2007070872A1 (en)	2005-12-15	2007-06-21	Rigel Pharmaceuticals, Inc.	Kinase inhibitors and their uses
EP1820502A1 (en) *	2006-02-10	2007-08-22	Laboratorios Del Dr. Esteve, S.A.	Active substance combination comprising azolylcarbinol compounds
WO2007113243A2 (en) *	2006-03-31	2007-10-11	Investigación Y Clínica Andrológicas S.L.	Use of pde 5 inhibitors for the treatment of overactive bladder
WO2008132589A1 (en) *	2007-05-01	2008-11-06	Pfizer Limited	Combinations comprising pregabalin
WO2009050554A2 (en) *	2007-10-19	2009-04-23	Pfizer Inc.	Treatment of central nervous system disorders
DE102008063992A1 (de) *	2008-12-19	2010-09-02	Lerner, Zinoviy, Dipl.-Ing.	Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
EP2691393B1 (en)	2011-03-31	2016-09-14	Pfizer Inc	Novel bicyclic pyridinones
WO2012172449A1 (en)	2011-06-13	2012-12-20	Pfizer Inc.	Lactams as beta secretase inhibitors
JP6043355B2 (ja)	2011-08-31	2016-12-14	ファイザー・インク	ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
JP6110937B2 (ja)	2012-05-04	2017-04-05	ファイザー・インク	ＡＰＰ、ＢＡＣＥ１、およびＢＡＣＥ２の阻害剤としての複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
EP2897964A1 (en)	2012-09-20	2015-07-29	Pfizer Inc.	Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
UA110688C2 (uk)	2012-09-21	2016-01-25	Пфайзер Інк.	Біциклічні піридинони
CA2893256A1 (en)	2012-12-11	2014-06-19	Pfizer Inc.	Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
CA2893333C (en)	2012-12-19	2017-10-24	Pfizer Inc.	Carbocyclic-and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
EP2956458B1 (en)	2013-02-13	2017-08-09	Pfizer Inc	Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
US9233981B1 (en)	2013-02-15	2016-01-12	Pfizer Inc.	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
EA201591360A1 (ru)	2013-02-19	2016-03-31	Пфайзер Инк.	Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
ES2742078T3 (es)	2013-10-04	2020-02-13	Pfizer	Piridonas bicíclicas novedosas como moduladores de gamma-secretasa
US20170037028A1 (en) *	2013-12-20	2017-02-09	Bayer Pharma Aktiengesellschaft	Glucose transport inhibitors
BR112016022519A8 (pt)	2014-04-01	2018-03-06	Pfizer	cromeno e 1,1a,2,7b-tetra-hidrociclopropa[c]cromeno piridopirazinadionas como moduladores de gama-secretase
US10005764B2 (en) *	2014-04-04	2018-06-26	H. Lundbeck A/S	Halogenated quinazolin-THF-amines as PDE1 inhibitors
CN106459088A (zh)	2014-04-10	2017-02-22	辉瑞公司	2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
WO2016012896A1 (en)	2014-07-24	2016-01-28	Pfizer Inc.	Pyrazolopyrimidine compounds
ES2733502T3 (es)	2014-08-06	2019-11-29	Pfizer	Compuestos de imidazopiridazina
MX368162B (es) *	2014-12-08	2019-09-20	Janssen Sciences Ireland Uc	Derivados de pirazolo[1,5-a]pirimidina sustituida con piperidina con actividad inhibidora sobre la replicacion del virus sincicial respiratorio (vsr).
ES2818806T3 (es)	2015-02-03	2021-04-14	Pfizer	Novedosas ciclopropabenzofuranil piridopirazindionas
HUE051898T2 (hu)	2015-06-17	2021-03-29	Pfizer	Triciklusos vegyületek és alkalmazásuk foszfodiészteráz inhibitorokként
WO2017051303A1 (en)	2015-09-24	2017-03-30	Pfizer Inc.	Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
JP2018531923A (ja)	2015-09-24	2018-11-01	ファイザー・インク	Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
EP3353174A1 (en)	2015-09-24	2018-08-01	Pfizer Inc	N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl]amides useful as bace inhibitors
WO2017145013A1 (en)	2016-02-23	2017-08-31	Pfizer Inc.	6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
JP7046018B2 (ja)	2016-07-01	2022-04-01	ファイザー・インク	神経性疾患および神経変性疾患を処置するための５，７－ジヒドロピロロピリジン誘導体
DK3642202T3 (da)	2017-06-22	2023-01-30	Pfizer	Dihydro-pyrrolo-pyridin-derivater
PL3768669T3 (pl)	2018-03-23	2023-07-03	Pfizer Inc.	Pochodne azaspiro piperazyny
MX2020013083A (es)	2018-06-04	2021-05-27	Exscientia Ltd	Compuestos de pirazolopirimidina como antagonistas del receptor de adenosina.
WO2020041741A1 (en) *	2018-08-24	2020-02-27	Terns, Inc.	Thyroid hormone receptor beta agonist compounds
CN111320609A (zh)	2018-12-13	2020-06-23	拓臻股份有限公司	一种THRβ受体激动剂化合物及其制备方法和用途
EP4297868A4 (en)	2021-02-23	2025-01-08	Hoth Therapeutics, Inc.	USE OF APREPITANT TO TREAT ALZHEIMER'S
WO2023171556A1 (ja) *	2022-03-10	2023-09-14	積水化学工業株式会社	ウイルス感染阻止剤、ウイルス感染阻止製品、ウイルス感染阻止塗料及び樹脂組成物
WO2024118524A1 (en)	2022-11-28	2024-06-06	Cerevel Therapeutics, Llc	Azaindole compounds and their use as phosphodiesterase inhibitors
WO2025145091A1 (en)	2023-12-29	2025-07-03	Pfizer Inc.	Crystalline forms of a muscarinic m4 receptor modulator and methods of treating diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW370529B (en) *	1992-12-17	1999-09-21	Pfizer	Pyrazolopyrimidines
AU5995699A (en) *	1998-10-23	2000-05-15	Bunnage, Mark Edward	Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
GB9823102D0 (en) *	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
DE10031236A1 (de) *	2000-06-27	2002-01-10	Qiagen Gmbh	Verwendung von Carbonsäuren und anderen Additiven in Kombination mit kationischen Verbindungen zur Stabilisierung von Nukleinsäuren in biologischen Materialien
DE10031584A1 (de) *	2000-06-29	2002-01-10	Merck Patent Gmbh	5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DK1348707T3 (da) *	2002-03-28	2010-12-13	Ustav Ex Botan Av Cr V V I Inst Of Ex Botany Academy Of Sciences Of The Czech Republic Pro	Pyrazolo[4,3-d]pyrimidiner, fremgangsmåder til deres fremstilling samt deres terapeutiske anvendelse
BRPI0409903A (pt) *	2003-04-29	2006-04-25	Pfizer Ltd	5,7-diamino-pirazol[4,3-d]pirimidina úteis no tratamento de hipertensão

2003
- 2003-11-24 GB GBGB0327319.0A patent/GB0327319D0/en not_active Ceased
2004
- 2004-11-12 CN CN200910151866A patent/CN101647802A/zh active Pending
- 2004-11-12 AU AU2004290643A patent/AU2004290643B2/en not_active Ceased
- 2004-11-12 OA OA1200600166A patent/OA13289A/en unknown
- 2004-11-12 CN CN2008100859397A patent/CN101362764B/zh not_active Expired - Fee Related
- 2004-11-12 ME MEP-2010-203A patent/ME01216B/me unknown
- 2004-11-12 ES ES04798876T patent/ES2351622T3/es not_active Expired - Lifetime
- 2004-11-12 KR KR1020067010152A patent/KR100848216B1/ko not_active Expired - Fee Related
- 2004-11-12 AT AT04798876T patent/ATE485297T1/de active
- 2004-11-12 HR HR20100651T patent/HRP20100651T1/hr unknown
- 2004-11-12 RS RSP-2010/0534A patent/RS51556B/en unknown
- 2004-11-12 MX MXPA06005914A patent/MXPA06005914A/es active IP Right Grant
- 2004-11-12 PL PL04798876T patent/PL1689751T3/pl unknown
- 2004-11-12 JP JP2006540647A patent/JP4056015B2/ja not_active Expired - Fee Related
- 2004-11-12 KR KR1020087009034A patent/KR100893999B1/ko not_active Expired - Fee Related
- 2004-11-12 CN CN2004800345707A patent/CN1882591B/zh not_active Expired - Fee Related
- 2004-11-12 NZ NZ548097A patent/NZ548097A/en not_active IP Right Cessation
- 2004-11-12 DK DK04798876.1T patent/DK1689751T3/da active
- 2004-11-12 GE GEAP20049412A patent/GEP20084528B/en unknown
- 2004-11-12 EP EP04798876A patent/EP1689751B1/en not_active Expired - Lifetime
- 2004-11-12 CN CN200810085940XA patent/CN101362765B/zh not_active Expired - Fee Related
- 2004-11-12 WO PCT/IB2004/003747 patent/WO2005049616A1/en active Application Filing
- 2004-11-12 CA CA002546987A patent/CA2546987C/en not_active Expired - Fee Related
- 2004-11-12 AP AP2006003591A patent/AP2227A/xx active
- 2004-11-12 BR BRPI0416869-0A patent/BRPI0416869A/pt not_active Application Discontinuation
- 2004-11-12 PT PT04798876T patent/PT1689751E/pt unknown
- 2004-11-12 DE DE602004029705T patent/DE602004029705D1/de not_active Expired - Lifetime
- 2004-11-12 SI SI200431562T patent/SI1689751T1/sl unknown
- 2004-11-12 SG SG200704860-6A patent/SG133614A1/en unknown
- 2004-11-12 EA EA200600677A patent/EA011772B1/ru not_active IP Right Cessation
- 2004-11-22 MY MYPI20044834A patent/MY140872A/en unknown
- 2004-11-22 PE PE2004001138A patent/PE20051061A1/es not_active Application Discontinuation
- 2004-11-22 UY UY28625A patent/UY28625A1/es active IP Right Grant
- 2004-11-23 AR ARP040104331A patent/AR046711A1/es not_active Application Discontinuation
- 2004-11-23 TW TW093136019A patent/TWI265031B/zh not_active IP Right Cessation
- 2004-11-23 NL NL1027568A patent/NL1027568C2/nl not_active IP Right Cessation
- 2004-11-23 PA PA20048617701A patent/PA8617701A1/es unknown
- 2004-12-11 UA UAA200605669A patent/UA81994C2/uk unknown
2006
- 2006-04-10 ZA ZA200602899A patent/ZA200602899B/en unknown
- 2006-04-10 IS IS8406A patent/IS8406A/is unknown
- 2006-05-04 IL IL175433A patent/IL175433A/en not_active IP Right Cessation
- 2006-05-23 EC EC2006006580A patent/ECSP066580A/es unknown
- 2006-05-23 CR CR8416A patent/CR8416A/es unknown
- 2006-05-24 MA MA29050A patent/MA28172A1/fr unknown
- 2006-05-24 TN TNP2006000154A patent/TNSN06154A1/fr unknown
- 2006-06-23 NO NO20062950A patent/NO336526B1/no not_active IP Right Cessation
2010
- 2010-11-24 CY CY20101101062T patent/CY1110933T1/el unknown

Also Published As

Publication number	Publication date
TW200520758A (en)	2005-07-01
RS51556B (en)	2011-06-30
ME01216B (me)	2013-03-20
ECSP066580A (es)	2006-12-20
WO2005049616A8 (en)	2006-06-01
DK1689751T3 (da)	2011-01-17
NZ548097A (en)	2008-12-24
ATE485297T1 (de)	2010-11-15
CN101362764B (zh)	2011-04-20
HK1128917A1 (en)	2009-11-13
WO2005049616A1 (en)	2005-06-02
PA8617701A1 (es)	2005-08-04
ZA200602899B (en)	2007-07-25
KR20070026334A (ko)	2007-03-08
HK1099286A1 (en)	2007-08-10
EP1689751A1 (en)	2006-08-16
TWI265031B (en)	2006-11-01
CN101362764A (zh)	2009-02-11
CN1882591A (zh)	2006-12-20
CN101362765B (zh)	2011-02-02
CN1882591B (zh)	2011-08-10
MY140872A (en)	2010-01-29
AP2006003591A0 (en)	2006-04-30
DE602004029705D1 (de)	2010-12-02
UA81994C2 (xx)	2008-02-25
MA28172A1 (fr)	2006-09-01
IL175433A0 (en)	2006-09-05
KR100848216B1 (ko)	2008-07-24
JP4056015B2 (ja)	2008-03-05
NO20062950L (no)	2006-08-23
AU2004290643A1 (en)	2005-06-02
CA2546987A1 (en)	2005-06-02
KR20080052666A (ko)	2008-06-11
EA200600677A1 (ru)	2006-12-29
SG133614A1 (en)	2007-07-30
CN101647802A (zh)	2010-02-17
CY1110933T1 (el)	2015-06-10
UY28625A1 (es)	2005-06-30
KR100893999B1 (ko)	2009-04-20
AP2227A (en)	2011-03-29
ES2351622T3 (es)	2011-02-08
PL1689751T3 (pl)	2011-03-31
TNSN06154A1 (fr)	2007-11-15
NL1027568A1 (nl)	2005-05-26
GB0327319D0 (en)	2003-12-24
NL1027568C2 (nl)	2005-11-30
CR8416A (es)	2006-11-15
OA13289A (en)	2007-01-31
AR046711A1 (es)	2005-12-21
GEP20084528B (en)	2008-11-10
CN101362765A (zh)	2009-02-11
EP1689751B1 (en)	2010-10-20
EA011772B1 (ru)	2009-06-30
SI1689751T1 (sl)	2011-01-31
CA2546987C (en)	2009-05-12
MXPA06005914A (es)	2006-06-27
BRPI0416869A (pt)	2007-03-27
IS8406A (is)	2006-04-10
IL175433A (en)	2011-08-31
PT1689751E (pt)	2010-11-29
NO336526B1 (no)	2015-09-21
AU2004290643B2 (en)	2008-08-07
PE20051061A1 (es)	2005-12-12
JP2007512314A (ja)	2007-05-17

Publication	Publication Date	Title
HRP20100651T1 (hr)	2011-01-31	5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINI S AKTIVNOSCU INHIBITORA PDE-5
AU2011257336B2 (en)	2015-11-19	The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
AU2011258436B2 (en)	2014-06-12	Soluble guanylate cyclase activators
AU2017382029B2 (en)	2022-02-17	Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-kinase inhibitors
JP6054967B2 (ja)	2016-12-27	置換アネレート化ピリミジンおよびその使用
KR101345956B1 (ko)	2014-02-06	Ｖｅｇｆ-ｒ2의 피리딜옥시인돌 억제제 및 질환의 치료를 위한 그의 용도
ES2340321T3 (es)	2010-06-01	Oxadiazolilpirazolo-pirimidinas, como antagonistas de mglur2.
ES2652514T3 (es)	2018-02-02	Compuestos heteroaromáticos como ligandos de dopamina D1
CA2743864A1 (en)	2010-06-10	Soluble guanylate cyclase activators
JP2018529739A (ja)	2018-10-11	セピアプテリン還元酵素としてのヘテロアリール誘導体
AU2008318491A1 (en)	2009-05-07	Cytokine inhibitors
CA2702315A1 (en)	2009-04-23	Combination 059
JP2006502119A (ja)	2006-01-19	新規２，５−二置換ピリミジン誘導体
ES2807785T3 (es)	2021-02-24	Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k
SG192756A1 (en)	2013-09-30	6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors
BR112016024455B1 (pt)	2023-02-07	Composto heterocíclico bicíclico ou tricíclico
CA2958671C (en)	2019-04-30	Imidazopyridazine compounds and their use
ES2998885T3 (en)	2025-02-24	Haloallylamine compounds and application thereof
CN111936144A (zh)	2020-11-13	Jak抑制剂
EP4472968A1 (en)	2024-12-11	Inhibitors of raf kinases
ES2208063A1 (es)	2004-06-01	Nuevos derivados de la 4-(pirrolopirimidin-6-il)bencenosulfonamida.
AU2022249724B2 (en)	2025-03-13	Pharmaceutical compound